Lineage Cell Therapeutics Stock Price. Everything You Need To Know About The Lineage Cell Therapeutics Stock! Lineage Cell Therapeutics Stock Price. Everything You Need To Know About The Lineage Cell Therapeutics Stock!


Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company is headquartered in Carlsbad, California and currently employs 78 full-time employees. The firm is focused on developing cell therapies to address unmet medical needs. The company designs, develops, and manufactures specialized human cells with anatomical and physiological functions which are similar or identical to cells found naturally in the human body. The company has five allogeneic product candidates: OpRegen, OPC1, VAC2, ANP1, and PNC1. OpRegen is a retinal pigment epithelium (RPE) cell replacement therapy in a Phase IIa development for the treatment of geographic atrophy secondary to age-related macular degeneration (AMD). OPC1 is an oligodendrocyte progenitor cell therapy in a Phase I/IIa development for the treatment of acute spinal cord injuries (SCI); VAC is a dendritic cell therapy produced from Lineages VAC technology platform for immuno-oncology and infectious disease, in Phase I clinical development for the treatment of non-small cell lung cancer.



Lineage Cell Therapeutics Stock Price. Everything You Need To Know About The Lineage Cell Therapeutics Stock! performance

  • Employees

    78
  • Company HQ

    Carlsbad
  • Website

    https://lineagecell.com/
  • LCTX Asset Type

    Common Stock
  • LCTX Market Capitalization

    263.9M
  • Earnings Per Share -0.12
  • Dividends Per Share None
  • Dividend Date None
  • Quarterly Earnings Growth 0

Are you interested in investing in Lineage Cell Therapeutics from Malaysia, Thailand, Indonesia, or Vietnam? Look no further than Zorion, the leading investment platform that gives retail investors access to real US stocks and Pre-IPO companies. Lineage Cell Therapeutics is a cutting-edge biotechnology company focused on developing innovative therapies for degenerative diseases. With Zorion, you can make informed investment decisions by accessing investment insights, recommendations, and educational materials tailored to your needs. Learn how to invest in Lineage Cell Therapeutics and join the ranks of successful investors. Start your investment journey with Zorion today!


Want To Buy Lineage Cell Therapeutics Stock From Malaysia, Indonesia, Thailand or Philippines? You may also be interested in: